Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se
Mandate

Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se

March 15, 2022 M&A

InnovDr is a digital provider of health and medical services. The business, which started in 2016, consists of Kollarna.se and the subareas urinkollen.se, aknekollen.se, borreliakollen.se, menskollen.se, ögonkollen.se and herpeskollen.se.

The owners of InnovDr divest the company to Doktor.se, which is one of the leading companies in digital care in Sweden.

Vinge’s team consisted of Wibeke Sorling, Jenny Sandlund, Hanna Jansson and Amanda Stoltz.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

 Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

 Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

 Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026